Bio-Techne Profit Margin

The latest profit margin for TECH is 14.97% as of June 2026. That compares with 6.02% in the prior-year period — up 148.7% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Bio-Techne's historical trend and sector peers before judging valuation or financial health.

Over the past year, TECH's profit margin moved from 6.02% to 14.97% — a 148.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bio-Techne's valuation or profitability profile.

Against Healthcare companies, TECH currently prints 14.97% for profit margin, while the sector average sits near 21.34%. That is roughly 29.8% below the sector mean. Large gaps often invite a closer look at Bio-Techne's growth, margins, and balance sheet.

Profit Margin shows how effectively Bio-Techne converts resources into returns. At 14.97%, TECH may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 6.02% in the prior-year period — up 148.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting TECH's profit margin (14.97%), review year-over-year change from 6.02%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.